Home/Filings/4/0001225208-24-006566
4//SEC Filing

Pegus Cheryl 4

Accession 0001225208-24-006566

CIK 0000885725other

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 4:29 PM ET

Size

9.0 KB

Accession

0001225208-24-006566

Insider Transaction Report

Form 4
Period: 2024-06-03
Pegus Cheryl
Director
Transactions
  • Award

    Deferred Stock Units

    2024-06-03+4073,207 total
    Common Stock (407 underlying)
  • Award

    Deferred Stock Units

    2024-06-03+2,8002,800 total
    Common Stock (2,800 underlying)
Footnotes (3)
  • [F1]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
  • [F2]Grant of deferred stock units to non-employee director following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2025 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Reflects a value of approximately $211,474 (representing 100% of the prorated amount of the non-employee director compensation program's annual equity award having a value of $215,000) divided by the closing price of the common stock on the date of grant. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan.
  • [F3]Grant of deferred stock units in lieu of 25% yearly cash compensation following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2025 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Reflects a value of approximately $30,737.50 (representing 25% of the prorated amount of the non-employee director compensation program's cash retainer having a value of $125,000) divided by the closing price of the common stock on the date of grant. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan.

Documents

1 file

Issuer

BOSTON SCIENTIFIC CORP

CIK 0000885725

Entity typeother

Related Parties

1
  • filerCIK 0001572448

Filing Metadata

Form type
4
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 4:29 PM ET
Size
9.0 KB